Document is current
Any future updates will be listed below
-
Authors
Carew, A. S.
Warren, R. A.
Bancks, M. P.
Espeland, M. A.
Bahnson, J. L.
Lewis, C. L.
Levy, A. P.
Sapp, J. L.
Urquhart, R.
Wang, J. L.
Rimm, E. B.
Cahill, L. E.
-
Funding
Funding for this research was provided by:
Heart and Stroke Foundation of Canada (Bright Red Mission Award)
Government of Nova Scotia (Graduate Scholarship)
Killam Trusts (Doctoral Award)
Canadian Institutes of Health Research (Doctoral Award, PJT173471)
National Institutes of Health (DK057136)
- License Information
-
More Information
Article History
Received: 17 July 2024
Accepted: 19 September 2024
First Online: 9 October 2024
Declarations
:
: Each participating center obtained ethical approval, and all participants provided written informed consent.
: One of our authors, Dr. Andrew Levy, is the author of a patent owned by his university regarding use of haptoglobin genotype to predict susceptibility to cardiovascular disease in individuals with diabetes.
